Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Hepatitis B virus markers in the internist's practice].

V T Ivashkin, A I Khazanov, A S Ivlev

Klinicheskaia Meditsina

|September 1, 1991

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Pathology of the digestive system organs in post-COVID syndrome according to autopsy data from 2021-2024].

Arkhiv patologii·2026

Same author

[Clinical and morphological features and functional parameters in patients with gastroesophageal reflux disease and Barrett's esophagus].

Terapevticheskii arkhiv·2025

Same author

[Efficacy and safety of bulevirtide in patients with chronic hepatitis D and compensated cirrhosis].

Terapevticheskii arkhiv·2022

Same author

[The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities].

Terapevticheskii arkhiv·2022

Same author

[Rebamipide using in gastroesophageal reflux disease treatment].

Terapevticheskii arkhiv·2020

Same author

[Changes in gut microbiota with bronchial asthma].

Terapevticheskii arkhiv·2020

Hepatitis B virus (HBV) infection has three outcomes: immunity, persistence, or replication. Two seroconversion types exist, with one rarely occurring but leading to severe complications.

Area of Science:

Hepatology
Virology
Immunology

Background:

Hepatitis B virus (HBV) infection presents complex interactions with the human immune system.
Understanding HBV's impact involves recognizing acquired immunity, viral persistence, and active replication.

Observation:

Two distinct patterns of seroconversion, the transition from Hepatitis B e-antigen (HBeAg) to anti-HBe antibodies, were observed.
These seroconversion forms differ significantly in their clinical presentation and outcomes.

Findings:

One common form of seroconversion is associated with a favorable prognosis for patients.
A rare form of seroconversion follows a severe clinical course, often leading to life-threatening complications.

Implications:

Related Experiment Videos

Identifying the type of seroconversion is crucial for predicting patient outcomes in Hepatitis B infection.
This distinction aids in tailoring clinical management strategies for HBV patients.
Further research into the mechanisms of severe seroconversion could reveal new therapeutic targets.